Showing results (111-120 of 387) with videos related to

Sort By:
Pageof 39
F1000Prime Reports|July 4, 2014
Management of pediatric uveitisBailey A Wentworth, Clovis A Freitas-Neto, C Stephen Foster
Journal of Ophthalmic & Vision Research|August 16, 2021
COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?Arash Maleki, Sydney Look-Why, Ambika Manhapra, et al.
Suicide & Life-Threatening Behavior|May 23, 2026
Honor Endorsement Strengthens Military Personnel's Help-Seeking Stigma Toward Mental HealthJarrod E Bock, Jacques De Villiers, Katy Jones, et al.
Ophthalmology|February 5, 2002
Multifocal choroiditis and panuveitis: immunomodulatory therapyShawkat Shafik Michel, Anthony Ekong, Stefanos Baltatzis, et al.
Biointerphases|September 14, 2010
Confinement and compression of an oligomer brushStephen Foster, Christopher Wainwright, Douglas B Staple, et al.
European Journal of Ophthalmology|September 10, 2015
A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titersSutasinee Boonsopon, Armin Maghsoudlou, Ninani E Kombo, et al.
Taiwan Journal of Ophthalmology|April 11, 2025
Results of long-term antiviral prophylactic treatment on the course of herpes zoster ophthalmicus with ocular involvement: A case series in a tertiary uveitis clinic - A 1-year follow-upArash Maleki, Priya D Patel, Amanda Colombo, et al.
Oman Journal of Ophthalmology|April 3, 2026
Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathyDiana Morvey, Arash Maleki, Paula Vivian Tan, et al.
Acta Ophthalmologica|March 25, 2016
Outcome of tocilizumab treatment in refractory ocular inflammatory diseasesSukhum Silpa-Archa, Merih Oray, Janine M Preble, et al.
Retina (Philadelphia, Pa.)|July 23, 2015
LONG-TERM EFFICACY OF SYSTEMIC INFLIXIMAB IN RECALCITRANT RETINAL VASCULITISPramod K Sharma, Gueorgui T Markov, Asima Bajwa, et al.
Pageof 39